“Clever Leaves has quickly established itself as a pioneering medical cannabis and hemp producer in Colombia, and this authorization solidifies our position as a leading Latin American exporter to federally-legal markets around the world. Up until this quota, Colombian production has largely emphasized hemp, and this quota marks the formal entry of Clever Leaves and Colombia into the burgeoning international medical cannabis industry,” said Kyle Detwiler, CEO of Clever Leaves.